General Information of This Drug (ID: DM96FA1)

Drug Name
Drotaverine   DM96FA1
Synonyms
drotaverine; Drotaverin; 14009-24-6; dihydroisoperparine; Drotaverine [INN]; No-Spa; Drotaverinum [INN-Latin]; Drotaverina [INN-Spanish]; UNII-98QS4N58TW; 98QS4N58TW; C24H31NO4; Drotaverine (INN); Drotin; isodihydroperparine; 1-(3,4-Diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline; (1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline; Drotaverina; Drotaverinum; Nospanum; 1-Benzyl-3',4',6,7-tetraethoxy-1,2,3,4-tetrahydroisoquinoline; No-shpa; 985-12-6; Drotin (TN); DIHYDROETHAVERINE
Indication
Disease Entry ICD 11 Status REF
Irritable bowel syndrome DD91.0 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Ibuprofen + Drotaverine DCA83J3 Ibuprofen Dysmenorrhea [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 ClinicalTrials.gov (NCT00292747) Drotaverine in Dysmenorrhoea Treatment